| Index | — | P/E | 6.50 | EPS (ttm) | 4.08 | Insider Own | 0.43% | Shs Outstand | 82.73M | Perf Week | 1.96% |
| Market Cap | 2.19B | Forward P/E | 6.67 | EPS next Y | 3.97 | Insider Trans | 0.00% | Shs Float | 44.60M | Perf Month | 9.28% |
| Enterprise Value | 2.40B | PEG | 0.32 | EPS next Q | 0.72 | Short Float | 6.26% | Perf Quarter | 5.70% | ||
| Income | 401.00M | P/S | 1.01 | EPS this Y | 58.60% | Short Ratio | 6.13 | Perf Half Y | 27.47% | ||
| Sales | 2.16B | P/B | 0.99 | EPS next Y | 29.62% | ROA | 3.73% | Short Interest | 2.79M | Perf YTD | — |
| Book/sh | 26.85 | P/C | 4.24 | EPS next 5Y | 20.52% | ROE | 17.25% | 52W High | 26.59 -0.56% | Perf Year | — |
| Cash/sh | 6.25 | P/FCF | 3.47 | EPS past 3/5Y | 67.37% 14.12% | ROIC | 3.73% | 52W Low | 19.88 33.00% | Perf 3Y | — |
| Dividend Est. | 0.60 (2.27%) | EV/EBITDA | 4.69 | Sales past 3/5Y | 12.73% 23.08% | Gross Margin | 51.16% | Volatility | 1.56% 1.98% | Perf 5Y | — |
| Dividend TTM | 0.60 (2.27%) | EV/Sales | 1.11 | EPS Y/Y TTM | — | Oper. Margin | 21.27% | ATR (14) | 0.51 | Perf 10Y | — |
| Dividend Ex-Date | Sep 14, 2026 | Quick Ratio | — | Sales Y/Y TTM | -14.58% | Profit Margin | 18.54% | RSI (14) | 67.76 | Recom | 2.86 |
| Dividend Gr. 3/5Y | — | Current Ratio | — | EPS Q/Q | 183.33% | SMA20 | 4.95% | Beta | -0.31 | Target Price | 24.63 |
| Payout | 14.00% | Debt/Eq | 0.32 | Sales Q/Q | 5.58% | SMA50 | 7.14% | Rel Volume | 0.65 | Prev Close | 26.50 |
| Employees | 108 | LT Debt/Eq | 0.32 | Earnings | Nov 11 | SMA200 | 11.57% | Avg Volume | 454.70K | Price | 26.44 |
| IPO Date | Jun 29, 2023 | Option/Short | Yes / Yes | EPS/Sales Surpr. | -61.31% 64.78% | Net Debt/EBITDA | 0.40 | Volume | 294,355 | Change | -0.23% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-13-26 | Reiterated | Barclays | Equal Weight | $24 → $23 |
| Jul-10-26 | Reiterated | Evercore ISI | In Line | $22 → $24 |
| Jul-08-26 | Reiterated | UBS | Buy | $29 |
| Jul-07-26 | Reiterated | Barclays | Equal Weight | $22 → $24 |
| Jul-01-26 | Reiterated | Goldman Sachs | Sell | $20 → $23 |
| May-15-26 | Reiterated | Barclays | Equal Weight | $22 |
| Jan-07-26 | Downgrade | JP Morgan | Neutral → Underweight |
Pelagos Insurance Capital Limited (PLGO) specializes in providing insurance and reinsurance services across strategic markets including Bermuda, the Republic of Ireland, and the United Kingdom. The company's operations are distinctly segmented into two primary areas: Insurance and Reinsurance. Within its Insurance segment, Pelagos offers a comprehensive array of products covering diverse risks such as property, marine, asset-backed finance, portfolio credit, aviation and aerospace, political risk, violence and terror, energy, and cyber, among other specialized insurance coverages. The Reinsurance segment, conversely, delivers solutions focused on property reinsurance, retrocession, and broad whole account reinsurance. Established in 2014, the firm officially adopted the name Pelagos Insurance Capital Limited in May 2026, having previously operated as Fidelis Insurance Holdings Limited. Its global headquarters are located in Pembroke, Bermuda.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,161 | 2,172 | 2,111 | 3,367 | — | — | — | |
| Cost of Goods Sold Incl. D&A | 1,056 | 1,751 | 1,844 | 1,197 | — | — | — | |
| Gross Profit | 1,107 | 421 | 266 | 2,170 | — | — | — | |
| Selling, General and Administrative Excl. Other | 84 | 97 | 94 | 83 | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | |
| Other Operating Expense | 562 | 49 | 36 | 39 | — | — | — | |
| Operating Income | 460 | 276 | 136 | 2,047 | — | — | — | |
| Interest Expense | 58 | 48 | 34 | 36 | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 58 | 48 | 34 | 36 | — | — | — | |
| Net Income Before Taxes | 460 | 276 | 136 | 2,047 | — | — | — | |
| Income Taxes | 59 | 50 | 23 | -85 | — | — | — | |
| Consolidated Net Income | 401 | 226 | 113 | 2,133 | — | — | — | |
| Net Income From Continuing Operations | 401 | 226 | 113 | 2,133 | — | — | — | |
| Net Income | 401 | 226 | 113 | 2,133 | — | — | — | |
| EPS (Recurring) | 4.11 | 2.12 | 0.98 | 18.65 | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 4.11 | 2.12 | 0.98 | 18.65 | — | — | — | |
| EPS (Diluted) | 4.08 | 2.11 | 0.98 | 18.65 | — | — | — | |
| EBITDA | 511 | 304 | 156 | 2,083 | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 6.48 | — | — | — | — | — | — | |
| Price To Sales Ratio | 1.04 | — | — | — | — | — | — | |
| Gross Margin | 51.23 | 19.38 | 12.60 | 64.45 | — | — | — | |
| Operating Margin | 21.29 | 12.71 | 6.44 | 60.80 | — | — | — | |
| Net Margin | 18.56 | 10.41 | 5.35 | 63.35 | — | — | — | |
| Shares Outstanding | 85 | 106 | 115 | 114 | — | — | — | |
| Market Capitalization | 2,247 | — | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — |